Download full-text PDF

Source
http://dx.doi.org/10.1002/mp.12016DOI Listing

Publication Analysis

Top Keywords

era igrt
4
igrt small-
4
small- focal-field
4
focal-field external
4
external beam
4
beam radiotherapy
4
radiotherapy brachytherapy
4
brachytherapy dying
4
dying modality
4
era
1

Similar Publications

Article Synopsis
  • Re-irradiation is common in precision oncology, but it's crucial to monitor previous doses to organs-at-risk (OAR) to prevent overdose, especially when using advanced techniques like SMART for targeting tumors near OAR.
  • The study analyzed 18 patients with lung or liver tumors, comparing different dose accumulation methods by assessing cumulative doses in both the planning target volumes (PTV) and OAR across adaptive and theoretical treatments.
  • Results showed significant dose increases to OAR, especially in the spinal cord, heart, and gastrointestinal areas during adaptive treatments, suggesting a risk of overdoses, while maintaining comparable PTV coverage compared to baseline plans.
View Article and Find Full Text PDF

Acquired hypogammaglobulinemia or secondary immunodeficiency (SID) occurs commonly in hematological malignancies with increasing incidence and complexity in the era of modern therapies. Despite current practice of immunoglobulin replacement (IgRT) in SID, the evidence is lacking, especially for newer treatments. We discuss the current evidence for IgRT in various disease groups including issues, such as actual or ideal body weight (IBW)-based dosing, length of treatment, antibiotic prophylaxis, and vaccination.

View Article and Find Full Text PDF

Subcutaneous immunoglobulins in chronic lymphocytic leukemia with secondary antibody deficiency. A monocentric experience during Covid-19 pandemics.

Hematol Oncol

August 2022

Sezione di Ematologia, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

Secondary antibody deficiency (SAD) is a frequent manifestation of chronic lymphocytic leukemia (CLL) that increases the risk of infections. However, no formal guideline are available regarding the eligibility for prophylaxis or the delivery method, dosage, frequency of administration and duration of immunoglobulin replacement therapy (IgRT). The aim of this study was to assess the efficacy and safety of subcutaneous IgRT (SCIg) and its impact on quality of life (QoL) of CLL pts in the Covid-19 era.

View Article and Find Full Text PDF

Background: The standard treatment of locally advanced rectal cancers (LARC) consists on neoadjuvant chemoradiotherapy followed by total mesorectal excision. Different data in literature showed a benefit on tumor downstaging and pathological complete response (pCR) rate using radiotherapy dose escalation, however there is shortage of studies regarding dose escalation using the innovative techniques for LARC (T3-4 or N1-2).

Aim: To analyze the role of neoadjuvant radiotherapy dose escalation for LARC using innovative radiotherapy techniques.

View Article and Find Full Text PDF

Early-stage squamous cell cancer (SCC) of the glottis has a good prognosis. Therefore, patients have long survival outcomes and may potentially suffer from late toxicities of radiotherapy. Radiotherapy with a conventional parallel-opposed-pair or anterior-oblique beam arrangements for stage 1 and 2 glottic SCC have field borders that traditionally cover the entire larynx, exposing organs-at-risk (e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!